Clinical Trial Detail

NCT ID NCT02603432
Title A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Pfizer
Indications

transitional cell carcinoma

Therapies

Avelumab

Age Groups: adult

No variant requirements are available.